Literature DB >> 10861473

Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology.

H Kanno1, S Kojya, T Li, M Ohsawa, S Nakatsuka, M Miyaguchi, Y Harabuchi, K Aozasa.   

Abstract

Lymphoproliferative diseases of the nasal cavity and paranasal sinuses occur frequently in Asian countries and are histologically categorized as monomorphic ordinary lymphoma and polymorphic reticulosis (PR) with apparent inflammatory cell infiltration. The large atypical cells in PR show natural-killer cell nature and frequently contain Epstein-Barr virus (EBV) DNA. Among the EBV genes involved in latent infection, those encoding EBV latent membrane proteins are frequently expressed in PR. Several cytotoxic T-lymphocyte (CTL) defined epitopes have been mapped to latent membrane proteins restricted with HLA-A2, -A11 or -A24 antigens. Thus, the HLA-A allele may affect the development of PR. To examine this possibility, HLA-A alleles of 25 patients with EBV(+) PR were determined with low-resolution polymerase chain reaction-based typing using HLA-A locus sequence-specific primer combinations. The frequency of HLA-A alleles including HLA-A2 and -A24 antigens in PR patients was lower than that in the normal Japanese population, but the difference was not significant. Since HLA-A2-restricted CTL responses are well delineated at the A2-subtype level, the A2-subtype of PR cases with HLA-A2 antigen was further determined by high-resolution genetic typing. The frequency of HLA-A*0201 in PR was significantly lower than in the normal population (p=0.0314). The HLA-A*0201-restricted CTL responses may thus function in vivo to suppress the development of overt lymphoma. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861473

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

2.  Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.

Authors:  Scott V Adams; Polly A Newcomb; Andrei R Shustov
Journal:  J Clin Oncol       Date:  2016-03-20       Impact factor: 44.544

3.  Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.

Authors:  Zheng Li; Yi Xia; Li-Na Feng; Jie-Rong Chen; Hong-Min Li; Jing Cui; Qing-Qing Cai; Kar Seng Sim; Maarja-Liisa Nairismägi; Yurike Laurensia; Wee Yang Meah; Wen-Sheng Liu; Yun-Miao Guo; Li-Zhen Chen; Qi-Sheng Feng; Chi Pui Pang; Li Jia Chen; Soo Hong Chew; Richard P Ebstein; Jia Nee Foo; Jianjun Liu; Jeslin Ha; Lay Poh Khoo; Suk Teng Chin; Yi-Xin Zeng; Tin Aung; Balram Chowbay; Colin Phipps Diong; Fen Zhang; Yan-Hui Liu; Tiffany Tang; Miriam Tao; Richard Quek; Farid Mohamad; Soo Yong Tan; Bin Tean Teh; Siok Bian Ng; Wee Joo Chng; Choon Kiat Ong; Yukinori Okada; Soumya Raychaudhuri; Soon Thye Lim; Wen Tan; Rou-Jun Peng; Chiea Chuen Khor; Jin-Xin Bei
Journal:  Lancet Oncol       Date:  2016-07-25       Impact factor: 41.316

Review 4.  Nasal NK/T-cell lymphoma: epidemiology and pathogenesis.

Authors:  Katsuyuki Aozasa; Tetsuya Takakuwa; Tadashi Hongyo; Woo-Ick Yang
Journal:  Int J Hematol       Date:  2008-02-08       Impact factor: 2.490

5.  Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study.

Authors:  Kefeng Wang; Hang Yang; Wenjun He; Yi Xia; Zhongjun Xia; Su Li; Huiqiang Huang; Zhiming Li; Panpan Liu; Wenqi Jiang
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

Review 6.  Molecular pathogenic pathways in extranodal NK/T cell lymphoma.

Authors:  Sanjay de Mel; Susan Swee-Shan Hue; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  J Hematol Oncol       Date:  2019-04-02       Impact factor: 17.388

7.  EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier.

Authors:  Brady Beltran; Renzo Salas; Pilar Quiñones; Domingo Morales; Fernando Hurtado; Esther Cotrina; Luis Riva; Jorge Castillo
Journal:  Infect Agent Cancer       Date:  2009-07-06       Impact factor: 2.965

8.  The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.

Authors:  Eun-Yoon Cho; Ki-Hyun Kim; Won-Seog Kim; Keon Hee Yoo; Hong-Hoe Koo; Young-Hyeh Ko
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

Review 9.  The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.

Authors:  Sanjay de Mel; Gwyneth Shook-Ting Soon; Yingting Mok; Tae-Hoon Chung; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

Review 10.  EBV and the Pathogenesis of NK/T Cell Lymphoma.

Authors:  Ivonne A Montes-Mojarro; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.